Pain Therapeutics Invited To Present At 26th Annual ROTH Conference

AUSTIN, Texas, March 6, 2014 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that Remi Barbier, Chairman, President & CEO, will present at ROTH Capital Partners' 26th Annual ROTH Conference on Monday, March 10 at 12:30 p.m. Pacific Time at the Ritz-Carlton, Laguna Niguel in Dana Point, California.

Those interested in listening to the presentation live via the internet may do so by visiting the Company's website at www.paintrials.com . A replay of the presentation will be available on the website for approximately two weeks following the presentation.

About Pain Therapeutics, Inc.

Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. The FDA has not approved any of our drug candidates for commercial sale.  For more information, please visit www.paintrials.com .
CONTACT: For More Information Contact:                  Peter S. Roddy         Vice President and Chief Financial Officer         Pain Therapeutics, Inc.         proddy@paintrials.com         (512) 501-2450                  Barbara Ryan         FTI Consulting         Barbara.ryan@fticonsulting.com         (212) 850-5679

If you liked this article you might like

Ultragenyx Makes Bid for Dimension Therapeutics - Biotech Movers

5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy

For Pain Therapeutics CEO, 3 FDA Rejections Are Worth $23 Million

Pfizer (PFE) Stock Falls After Dropping Pain Drug

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan